Accelerated Adaptation of Ultrahypofractionated Radiation Therapy for Breast Cancer at the Time of the COVID-19 Pandemic

Autor: W. Vingerhoed, Charlotte Billiet, Dirk Verellen, R. Weytjens, M. Machiels, W. Bauwens, Philip Poortmans, Piet Dirix, Paul Meijnders, P. Huget, Orit Kaidar-Person

Publikováno v: Clinical Oncology (Royal College of Radiologists (Great Britain)
Clinical oncology, 33(3), E166-E171. Elsevier Science
Clinical Oncology
Clinical oncology

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32213c3573d644a31938b8f896ae2d4f
http://europepmc.org/articles/PMC7834150

Ultrahypofractionated radiation therapy for breast cancer: two-year normal tissue effects

Autor: R. Oulkadi, S. Amrouch, A. Dabach, K. Schaerlaeken, R. Weytjens, C. Billiet, P. Poortmans, M. Machiels

Publikováno v: European Journal of Cancer. 175:S46

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f0fe6881a6aa36eb76aee49bf20f3690
https://doi.org/10.1016/s0959-8049(22)01472-1

The use of simulation-CT’s as a coronavirus disease 2019 screening tool during the severe acute respiratory syndrome coronavirus 2 pandemic☆

Autor: I. Joye, Peter B. Vermeulen, M. Machiels, Ibrahim Chiari, Paul Meijnders, Ann Vermylen, R. Weytjens, P. Huget, Dirk Verellen, Daan Nevens, Luc Dirix, Charlotte Billiet, Ward Bauwens, Piet Dirix

Publikováno v: Radiotherapy and Oncology

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a3aeb14323d4607627b87d4d7bf2937
http://europepmc.org/articles/PMC7361078

Oncological outcome, postoperative complications, and mammographic changes after intraoperative radiotherapy with electrons (IOERT) as a boost in a large single-institution cohort of breast cancer patients

Autor: Katrien Erven, Peter B. Vermeulen, Steven Van Laere, Jasmijn M Westerhoff, Souad Amrouch, Luc Verkinderen, Michiel Strijbos, Piet Dirix, Charlotte Billiet, Peter van Dam, Jan Hauspy, R. Weytjens, Jana Bosiers, Piet Stevens, M. Machiels, Anja Bernaerts, Paul Meijnders, Dirk Verellen

Publikováno v: breast journal, 26(10), 1937-1945. Wiley-Blackwell
Breast journal

Advantages of using intraoperative radiotherapy with electrons (IOERT) as a boosting modality in breast-conserving therapy include the direct visualization of the tumor bed, a reduced skin dose, and patient convenience. We report oncological outcome,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e92595be161e59155fa4d260a0a195a
https://pubmed.ncbi.nlm.nih.gov/32779870

The TRENDY multi-center randomized trial on hepatocellular carcinoma - Trial QA including automated treatment planning and benchmark-case results

Autor: Michel Öllers, Niek van Wieringen, Xavier Mirabel, Ben J.M. Heijmen, François E. J. A. Willemssen, Karin Haustermans, Alejandra Méndez Romero, M. Wendling, L. Depuydt, Onne Reerink, Roy S. Dwarkasing, Oliver Riesterer, Wilko F.A.R. Verbakel, Enrica Seravalli, Cornelis J.A. Haasbeek, Steven J. M. Habraken, Abdul Wahab M. Sharfo, Thomas Lacornerie, Pètra M. Braam, Henrike Westerveld, Tom Depuydt, Jeroen Buijsen, Stephanie Tanadini-Lang, R. Weytjens

Publikováno v: Radiotherapy and oncology, 125(3), 507-513. Elsevier Ireland Ltd
Radiotherapy and oncology
Radiotherapy and Oncology, 125, 507-513
Habraken, S J M, Sharfo, A W M, Buijsen, J, Verbakel, W F A R, Haasbeek, C J A, Öllers, M C, Westerveld, H, van Wieringen, N, Reerink, O, Seravalli, E, Braam, P M, Wendling, M, Lacornerie, T, Mirabel, X, Weytjens, R, Depuydt, L, Tanadini-Lang, S, Riesterer, O, Haustermans, K, Depuydt, T, Dwarkasing, R S, Willemssen, F E J A, Heijmen, B J M & Méndez Romero, A 2017, ' The TRENDY multi-center randomized trial on hepatocellular carcinoma – Trial QA including automated treatment planning and benchmark-case results ', Radiotherapy and Oncology, vol. 125, no. 3, pp. 507-513 . https://doi.org/10.1016/j.radonc.2017.09.007
Radiotherapy and Oncology, 125(3), 507-513. Elsevier Ireland Ltd
Radiotherapy and Oncology, 125, 3, pp. 507-513

Background and purpose: The TRENDY trial is an international multi-center phase-II study, randomizing hepatocellular carcinoma (HCC) patients between transarterial chemoembolization (TACE) and stereotactic body radiation therapy (SBRT) with a target

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cc7b8d1e5d0f8c4993e0ccdd74dd4a9
https://hdl.handle.net/1765/102456